IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Actinium Pharmaceuticals Inc

CUSIP: 00507W907 | 4 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile